The aim of this study was to explore how an effective multidisciplinary perspective and DBS triple-testing (alpha-Gal A, Lyso-GL-3, GLA gene) could be used for screening and management of children with FD at a tertiary children’s hospital in China. This evidence concerns the gene GLA and Fabry disease.